Development
Cardio Diagnostics Holdings, Inc.
CDIO
$4.77
$0.2455.42%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 1,311.11% | 200.00% | 11.11% | 11.11% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1,311.11% | 200.00% | 11.11% | 11.11% | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1,311.11% | 200.00% | 11.11% | 11.11% | -- |
| SG&A Expenses | 230.31% | 465.08% | 783.66% | 682.74% | -- |
| Depreciation & Amortization | 15.00% | 10.00% | 5.00% | 0.00% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 242.50% | 454.18% | 743.37% | 632.02% | -- |
| Operating Income | -242.09% | -454.34% | -744.31% | -632.94% | -- |
| Income Before Tax | -278.58% | -465.92% | -601.40% | -651.06% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -278.58% | -465.92% | -601.40% | -651.06% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -278.58% | -465.92% | -601.40% | -651.06% | -- |
| EBIT | -242.09% | -454.34% | -744.31% | -632.94% | -- |
| EBITDA | -242.13% | -459.46% | -761.29% | -649.69% | -- |
| EPS Basic | -79.74% | -84.24% | -61.62% | -34.70% | -- |
| Normalized Basic EPS | -82.92% | -85.87% | -64.26% | -30.19% | -- |
| EPS Diluted | -79.74% | -84.24% | -61.62% | -34.70% | -- |
| Normalized Diluted EPS | -82.92% | -85.87% | -64.26% | -30.19% | -- |
| Average Basic Shares Outstanding | 123.61% | 180.55% | 272.05% | 409.24% | -- |
| Average Diluted Shares Outstanding | 123.61% | 180.55% | 272.05% | 409.24% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |